Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brabletz, T.
Right arrow Articles by Freund, J.-N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brabletz, T.
Right arrow Articles by Freund, J.-N.
[Cancer Research 64, 6973-6977, October 1, 2004]
© 2004 American Association for Cancer Research


Regular Articles

Down-Regulation of the Homeodomain Factor Cdx2 in Colorectal Cancer by Collagen Type I

An Active Role for the Tumor Environment in Malignant Tumor Progression

Thomas Brabletz1, Simone Spaderna1, Jochen Kolb1, Falk Hlubek1, Gerhard Faller1, Christiane J. Bruns2, Andreas Jung1, Jens Nentwich1, Isabelle Duluc3, Claire Domon-Dell3, Thomas Kirchner1 and Jean-Noel Freund3

1 Department of Pathology, University of Erlangen-Nürnberg, Erlangen, Germany; 2 Department of Surgery, University of Munich, Munich, Germany; and 3 INSERM, Unit 381, Strasbourg, France

The homeobox transcription factor Cdx2 specifies intestinal development and homeostasis and is considered a tumor suppressor in colorectal carcinogenesis. However, Cdx2 mutations are rarely found. Invasion of colorectal cancer is characterized by a transient loss of differentiation and nuclear accumulation of the oncoprotein ß-catenin in budding tumor cells. Strikingly, this is reversed in growing metastases, indicating that tumor progression is a dynamic process that is not only driven by genetic alterations but also regulated by the tumor environment. Here we describe a transient loss of Cdx2 in budding tumor cells at the tumor host interface, and reexpression of Cdx2 in metastases. Cell culture experiments show that collagen type I, through ß1 integrin signaling, triggers a transient transcriptional down-regulation of Cdx2 and its intestine-specific target gene sucrase isomaltase, associated with a loss of differentiation. These data indicate an active role for the tumor environment in malignant tumor progression.




This article has been cited by other articles:


Home page
Cancer Res.Home page
S. Spaderna, O. Schmalhofer, M. Wahlbuhl, A. Dimmler, K. Bauer, A. Sultan, F. Hlubek, A. Jung, D. Strand, A. Eger, et al.
The Transcriptional Repressor ZEB1 Promotes Metastasis and Loss of Cell Polarity in Cancer
Cancer Res., January 15, 2008; 68(2): 537 - 544.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
F. Benahmed, I. Gross, D. Guenot, F. Jehan, E. Martin, C. Domon-Dell, T. Brabletz, M. Kedinger, J.-N. Freund, and I. Duluc
The Microenvironment Controls CDX2 Homeobox Gene Expression in Colorectal Cancer Cells
Am. J. Pathol., February 1, 2007; 170(2): 733 - 744.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J. Galle, D. Sittig, I. Hanisch, M. Wobus, E. Wandel, M. Loeffler, and G. Aust
Individual Cell-Based Models of Tumor-Environment Interactions: Multiple Effects of CD97 on Tumor Invasion
Am. J. Pathol., November 1, 2006; 169(5): 1802 - 1811.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
K. Hotary, X.-Y. Li, E. Allen, S. L. Stevens, and S. J. Weiss
A cancer cell metalloprotease triad regulates the basement membrane transmigration program
Genes & Dev., October 1, 2006; 20(19): 2673 - 2686.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. E. Witek, K. Nielsen, R. Walters, T. Hyslop, J. Palazzo, S. Schulz, and S. A. Waldman
The Putative Tumor Suppressor Cdx2 Is Overexpressed by Human Colorectal Adenocarcinomas
Clin. Cancer Res., December 15, 2005; 11(24): 8549 - 8556.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2004 by the American Association for Cancer Research.